1Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr, 2000,130(2):129-132.
2Rosenblatt DS. Methylenetetrahydrofolate reductase. Clin Invest Med,2001,24(1):56-59.
3Sheth JJ, Sheth FJ .Gene polymorphism and folate metabolism: a maternal risk factor for Down syndrome.India Pediatr, 2003,40(2): 115-123.
4Scholl TO,Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr, 2000,71 [5 Suppl]: 1295-1303.
5Fodinger M, Hod WH, Sunder G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol, 2000,13(1):20-33.
6Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase (MTHFR) gene variants and congenital anomalies: a huge review. Am J Epidemiol, 2000,151 (9) : 862-877.
7Robien K,Ulrich CM. 5,10-Methylenetetrahydrofolate reductase Polymorphisms and leukemia risk: a huge minireview. Am J Epidemiol,2003,157:571-582.
8Schneider JA, Rees DC, Liu YT,et al. World wide distribution of a common methylenetetrahydrofolate reduetase mutation. Am J Hum Genet, 1998,62(5): 1258-1260.
9Abu-Amero KK, Wyngaard CA, Dzimiri N. Prevalence and role of methylenetetrahydrofolate reduetase 677 C→T and 1298 A→C polymorphisms in coronary artery disease in Arabs. Arch Pathol Lab Med,2003,127(10): 1349-1352.
10Ling KH, Rosli R, Duraismny G, et al. The prevalence of MTHFR 677C→T missense mutation, total plasma homocysteine levels and associated risk factors in malay subjects Med J Malaysia,2003,58(2):243-254.
